ACG Experts Highlight Key Abstracts, Offer Real-World Insights in Pre-Recorded Virtual Press Briefings

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

    This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to hepatitis C, inflammatory bowel disease, drug induced liver injury, nonalcoholic fatty liver disease, fecal microbiota transplantation and C. difficile. Notable case reports related to protein shakes, chia seeds, and other supplementation where good health intentions go bad are also featured. In these briefings, ACG experts offer their perspectives on the significance of the findings in relation to the larger issues surrounding these GI-related topics as well as tips for clinicians and patients. Links to author commentary and the abstracts are available on this page for each abstract featured in the briefings.


    John R. Saltzman, MD, FACG

    John R. Saltzman, MD, FACG

    ACG 2014 Highlights – Overview

    John R. Saltzman, MD, FACG, Chair of the ACG Educational Affairs Committee, offers his insight on ACG 2014’s most groundbreaking research, educational sessions and must-see lecture  in this virtual press briefing.

    Listen now

     

     


     

    Hepatitis C (HCV)

    David E. Bernstein, MD, FACG

    David E. Bernstein, MD, FACG

    Paul Y. Kwo, MD, FACG

    Paul Y. Kwo, MD, FACG

    David E. Bernstein, MD, FACG and Paul Y. Kwo, MD, FACG provide insight on the following abstracts:

    Oral 4 SVR12 of 99% Achieved With a Ribavirin-Free Regiment of ABT-450r Ombitasvir and Dasabuvir in HCV Genotype 1b-Infected Patients
    Read author insight and access abstract

    Oral 5 Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With  Cirrhosis After Treatment With ABT -450/R/Ombitasvir, Dasabuvir and Ribavirin
    Read author insight and access abstract

    Listen to the briefing


    Russell D. Cohen, MD, FACG

    Russell D. Cohen, MD, FACG

    Inflammatory Bowel Disease (IBD)

    Russell Cohen, MD, FACG, provides insight on the following abstracts:

    P454 Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Patients With Inflammatory Bowel Disease
    Read author insight and access abstract

    Oral 61 Association of Mean Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Prospective Study
    Read author insight and access abstract

    P1654 Pediatric Crohn’s Disease, Unrealized Height and Diminished Lifetime Earnings
    Read author insight and access abstract

    P573 A Randomized, Controlled Trial of Yoga in Pediatric Inflammatory Bowel Disease: Preliminary Findings
    Read author insight and access abstract

    Listen to the briefing

     


    Mark Mellow, MD, FACG

    Mark Mellow, MD, FACG

    Fecal Microbiota Transplantation (FMT) and C. difficile

    Mark Mellow, MD, FACG, provides insight on the following abstracts:

    Oral 72 Fresh, Frozen, or Lyophilized Fecal Microbiota Transplantation (FMT) for Multiple Recurrent C. difficile Infection (CDI)
    Read author insight and access abstract

    Poster 939 Safety Outcomes After Fecal Microbiota Transplantation (FMT) For C. difficile Infection (CDI)
    Read author insight and access abstract

    Oral 71 C. difficile Associated Risk of Death Score (CARDS): A Novel Risk Score to Predict Mortality Among Hospitalized Patients With C. difficile Infection
    Read author insight and access abstract

    Poster 1639 Fecal Microbiota Transplant for Treatment of Refractory C. difficile Colitis: Long-Term Follow-Up of 58 Patients
    Read author insight and access abstract

    Listen to the briefing


    James Lewis, MD, FACG

    James Lewis, MD, FACG

    Drug Induced Liver Injury and Non-Alcoholic Fatty Liver Disease (NAFLD)

    James Lewis, MD, FACG provides insight on the following abstracts

    Oral 28 Association Between Aspirin Use and Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study From the Third National Health and Nutrition Examination Survey
    Read author insight and access abstract

    Oral 31 Idiosyncratic Drug-Induced Liver Injury (DILI) in the United States: A Report of 1,257 Prospectively Enrolled Patients
    Read author insight and access abstract

    Poster 1441 Association Between Caffeine Consumption and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
    Read author insight and access abstract

    Listen to the briefing

    Access the ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury


    Patricia Raymond, MD, FACG

    Patricia Raymond, MD, FACG

    Health No Nos

    Patricia Raymond, MD, FACG  provides insight on these notable case reports related to protein shakes, chia seeds, and other supplementation where good health intentions go bad:

    Poster 280 First Case of Fatal Renal and Fulminant Hepatic Failure from Muscle Building Supplements
    Read author insight and access abstract

    Poster 643 Watch It Grow: Esophageal Impaction With Chia Seeds
    Read author insight and access abstract

    Poster 1296 Protein Shakes: An Unusual Cause of Gastric Phytobezoar in a Health Obsessed Person
    Read author insight and access abstract

    Poster1579 Getting Burned by Activated Charcoal: A Case of Colitis Associated With Activated Charcoal Use
    Read author insight and access abstract

    Poster 369 Supplement-Induced Acute Colonic Pseudo-Obstruction in Healthy Young Male
    Read author insight and access abstract

    Poster 1261 Desiccant-Induced Esophageal Obstruction: An Emerging Patient Safety Issue
    Read author insight and access abstract

    Listen to the briefing


     Media Interview Requests:

    To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.

     

     

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks